Status:
COMPLETED
Observational Study to Evaluate the Current Neuromuscular Monitoring Practice Used After Different Types of Surgery, for Which Neuromuscular Blocking Agents Were Used, With or Without Blocking Reversal (P06556)
Lead Sponsor:
Merck Sharp & Dohme LLC
Conditions:
Neuromuscular Monitoring After Administration of Neuromuscular Blocking Agents in Different Types of Surgery
Eligibility:
All Genders
18-65 years
Brief Summary
The intent of this observational study is to collect prospective data regarding neuromuscular monitoring practices and extubation standards (Train-Of-Four \[TOF\] value) during surgery, in countries o...
Eligibility Criteria
Inclusion
- Inclusion Criteria
- All of the criteria below must be met for a participant to be eligible for study participation.
- The prospective participant:
- Is an adult, 18 to 65 years-of-age;
- Is to undergo surgery requiring general anesthesia with non-depolarizing NMBA administration, with or without NMB reversal;
- Meets the inclusion criteria listed on the NMBA label in each country;
- Is willing to participate and sign an informed consent form (ICF).
- Exclusion Criteria
- Exclusion from the study will be determined by the treating physician. In addition the criteria below should be considered in determining those participants who should be excluded from the study.
- The prospective participant:
- Is pregnant or breast feeding;
- Has a neuromuscular disorder;
- Has severe hepatic impairment;
- Has severe renal impairment.
Exclusion
Key Trial Info
Start Date :
September 1 2010
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
February 1 2012
Estimated Enrollment :
659 Patients enrolled
Trial Details
Trial ID
NCT01213264
Start Date
September 1 2010
End Date
February 1 2012
Last Update
March 17 2015
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.